Manufacturing Today Issue 210 Issue 210 March 2023 | Page 161

Recordati
Advanced treatment options
However , the group ’ s subsidiary , Recordati Rare Diseases , is one of the most research-active companies in its field , continuously striving to uncover opportunities that address gaps in healthcare . Believing that every individual has the right to effective treatments , it focuses on helping people with few or no available options . It is particularly passionate about the fight against cancer , providing physicians and patients with advanced treatment options and supportive care products . At a practical level , a new , direct distribution and packaging system enables Recordati Rare Diseases to deliver small quantities of specialist products across the globe , often with short notice .
On the topic of acquisition , Recordati also obtained a rare disease product from Novartis in 2019 , which has enabled it to operate a unique production technique in Basel , Switzerland , based on a patent held by Novartis . “ We gained the technology to produce specific rare diseases pharmaceuticals , which uses methanol to slowly release microparticles ,” Roberto explains . “ We also took over the
manufacturing-today . com 161